EA201270376A1 - Антрахинондиоксимы и их применение - Google Patents
Антрахинондиоксимы и их применениеInfo
- Publication number
- EA201270376A1 EA201270376A1 EA201270376A EA201270376A EA201270376A1 EA 201270376 A1 EA201270376 A1 EA 201270376A1 EA 201270376 A EA201270376 A EA 201270376A EA 201270376 A EA201270376 A EA 201270376A EA 201270376 A1 EA201270376 A1 EA 201270376A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- anthrainedioxymes
- application
- derivatives
- compounds
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
В изобретении раскрыты антрахинондиоксимы и их производные для применения в лечении заболеваний, в частности рака, например рака толстой кишки и колоректального рака. Кроме того, в изобретении представлены способы синтеза упомянутых производных. Также описаны композиции этих соединений и метаболиты указанных соединений, а также их применение в модулировании генов.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/012995 WO2010059142A1 (en) | 2008-11-21 | 2008-11-21 | Anthraquinone dioximes and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201270376A1 true EA201270376A1 (ru) | 2012-12-28 |
EA022290B1 EA022290B1 (ru) | 2015-12-30 |
Family
ID=42198382
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201500218A EA030302B1 (ru) | 2008-11-21 | 2008-11-21 | Антрахинондиоксимы и их применение |
EA201270376A EA022290B1 (ru) | 2008-11-21 | 2008-11-21 | Антрахинондиоксимы и их применение |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201500218A EA030302B1 (ru) | 2008-11-21 | 2008-11-21 | Антрахинондиоксимы и их применение |
Country Status (2)
Country | Link |
---|---|
EA (2) | EA030302B1 (ru) |
WO (1) | WO2010059142A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013067547A1 (en) * | 2011-11-06 | 2013-05-10 | Beta Cat Pharmaceuticals, Llc | METHODS FOR TREATMENT OF DISEASES AND DISORDERS RELATED TO TRANSDUCIN β-LIKE PROTEIN 1 (TBL 1) ACTIVITY, INCLUDING MYELOPROLIFERATIVE NEOPLASIA AND CHRONIC MYELOID LEUKEMIA |
TW201718495A (zh) | 2015-07-28 | 2017-06-01 | 貝塔貓製藥股份有限公司 | 蒽-9, 10-二酮二肟化合物前驅藥及其用途 |
WO2017058716A1 (en) * | 2015-09-28 | 2017-04-06 | Vivace Therapeutics, Inc. | Tricyclic compounds |
CN105837478B (zh) * | 2016-04-20 | 2017-11-14 | 成都理工大学 | 作为p2x3和p2x2/3受体拮抗剂的双磺酰基蒽二酮双肟衍生物 |
EP3630101A4 (en) | 2017-06-02 | 2021-01-20 | Iterion Therapeutics, Inc. | DISEASE TREATMENT METHODS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3627791A (en) * | 1968-11-21 | 1971-12-14 | Richardson Merrell Inc | Bis(aminoalkylsulfamoyl) anthraquinones |
GB2025954A (en) * | 1978-07-21 | 1980-01-30 | Ciba Geigy Ag | Anthraquinone Sulphonamides |
GB2166453B (en) * | 1984-08-01 | 1987-10-28 | Ciba Geigy Ag | Purification process |
AU2003232785A1 (en) * | 2002-07-17 | 2004-02-02 | Zentaris Gmbh | Novel anthracene derivatives and the use thereof as a medicament |
US6693136B1 (en) * | 2002-07-26 | 2004-02-17 | Abbott Laboratories | Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors |
US6949557B2 (en) * | 2003-04-29 | 2005-09-27 | Dabur Research Foundation | Hydroanthracene based compounds as anticancer agents |
-
2008
- 2008-11-21 EA EA201500218A patent/EA030302B1/ru not_active IP Right Cessation
- 2008-11-21 EA EA201270376A patent/EA022290B1/ru not_active IP Right Cessation
- 2008-11-21 WO PCT/US2008/012995 patent/WO2010059142A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010059142A1 (en) | 2010-05-27 |
EA022290B1 (ru) | 2015-12-30 |
EA201500218A1 (ru) | 2015-09-30 |
EA030302B1 (ru) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200870569A1 (ru) | Соединения и способы модуляции fxr | |
EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
EA200870415A1 (ru) | Хиназолины для ингибирования pdk 1 | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
RU2448096C3 (ru) | Диарилгидантоины | |
EA201101650A1 (ru) | Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний | |
EA201070148A1 (ru) | Соединения и способы модулирования фарнезоидного рецептора x (fxr) | |
EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
EA200801362A1 (ru) | Пиримидинил бензотиофеновые соединения | |
EA201000016A1 (ru) | Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями | |
EA200801041A1 (ru) | Ингибиторы мек и способы их применения | |
EA200870116A1 (ru) | Бициклические гетероарильные соединения | |
NO20073788L (no) | Kjemiske forbindelser | |
EA201070247A1 (ru) | Ингибиторы протеасом | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
MA32508B1 (fr) | Composes organiques | |
EA201490132A1 (ru) | Противовирусные соединения | |
EA201101182A1 (ru) | Новые аминоазагетероциклические карбоксамиды | |
EA201100299A1 (ru) | Органические соединения | |
EA201290727A1 (ru) | Пирролбензодиазепины и их конъюгаты | |
DK1853602T3 (da) | Kemiske forbindelser | |
EA201000550A1 (ru) | Производные тиазола | |
EA201170531A1 (ru) | Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
EA201300610A1 (ru) | Хиназолинкарбоксамидазетидины |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |